ReviewTherapeutic advances in medical oncology2022

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review.

Isabel Heidegger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.